(MOH) Molina Healthcare - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US60855R1005

MOH: Health, Insurance, Medicaid, Medicare, Marketplace, Plans

Molina Healthcare, Inc. (NYSE: MOH) operates as a managed healthcare provider, primarily serving low-income individuals and families. Its core offerings are delivered through Medicaid, Medicare, and state insurance marketplaces, with operations spanning 19 states. The company, founded in 1980 and headquartered in Long Beach, California, is structured into four main business segments: Medicaid, Medicare, Marketplace, and Other.

As of the latest data, Molina Healthcare has a market capitalization of approximately $15.22 billion, reflecting its significant scale in the managed healthcare sector. The company trades with a trailing P/E ratio of 13.26 and a forward P/E of 11.03, suggesting expectations of stable earnings growth. Its price-to-book ratio stands at 3.34, while the price-to-sales ratio is 0.40, indicating moderate valuation relative to its revenue.

Investors should note that Molinas business model is heavily reliant on government-funded programs, which can be subject to regulatory changes and reimbursement rate fluctuations. However, the companys focus on underserved populations positions it in a growing market segment. Its ability to manage healthcare costs and navigate complex regulatory environments is critical to its long-term profitability.

For fund managers, Molinas consistent revenue growth and its role as a key player in the Medicaid and Medicare spaces make it a candidate for portfolios seeking exposure to the managed healthcare sector. However, careful consideration of policy risks and the companys ability to adapt to shifting healthcare landscapes is essential.

Additional details about the company can be found at: https://www.molinahealthcare.com.

Ticker Symbol: MOH Exchange: NYSE Type: common stock Country Origin: United States GICS Sub Industry: Managed Health Care Market Cap or AUM: 15022.19M USD P/E: 13.26 P/E Forward: 11.03 P/B: 3.34 P

Additional Sources for MOH Stock

MOH Stock Overview

Market Cap in USD 15,022m
Sector Healthcare
Industry Healthcare Plans
GiC Sub-Industry Managed Health Care
IPO / Inception 2003-07-02

MOH Stock Ratings

Growth 5y 40.9%
Fundamental 50.5%
Dividend 0.0%
Rel. Strength Industry -30.5
Analysts 3.64/5
Fair Price Momentum 264.26 USD
Fair Price DCF 159.10 USD

MOH Dividends

No Dividends Paid

MOH Growth Ratios

Growth Correlation 3m -24.5%
Growth Correlation 12m -71%
Growth Correlation 5y 76.3%
CAGR 5y 15.45%
CAGR/Max DD 5y 0.42
Sharpe Ratio 12m -0.77
Alpha -40.58
Beta 0.42
Volatility 42.98%
Current Volume 1063.4k
Average Volume 20d 815.4k
What is the price of MOH stocks?
As of February 22, 2025, the stock is trading at USD 283.81 with a total of 1,063,440 shares traded.
Over the past week, the price has changed by +4.23%, over one month by -4.58%, over three months by -4.14% and over the past year by -28.88%.
Is Molina Healthcare a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Molina Healthcare (NYSE:MOH) is currently (February 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 50.47 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MOH as of February 2025 is 264.26. This means that MOH is currently overvalued and has a potential downside of -6.89%.
Is MOH a buy, sell or hold?
Molina Healthcare has received a consensus analysts rating of 3.64. Therefor, it is recommend to hold MOH.
  • Strong Buy: 5
  • Buy: 0
  • Hold: 8
  • Sell: 1
  • Strong Sell: 0
What are the forecast for MOH stock price target?
According to ValueRays Forecast Model, MOH Molina Healthcare will be worth about 298.9 in February 2026. The stock is currently trading at 283.81. This means that the stock has a potential upside of +5.31%.
Issuer Forecast Upside
Wallstreet Target Price 336.3 18.5%
Analysts Target Price 358.5 26.3%
ValueRay Target Price 298.9 5.3%